AAAAAA
Results:
1-7
|
Results: 7
Authors:
TAIMINEN TJ
SALOKANGAS RKR
SAARIJARVI S
NIEMI H
LEHTO H
AHOLA V
SYVALAHTI E
Citation: Tj. Taiminen et al., SMOKING AND COGNITIVE DEFICITS IN SCHIZOPHRENIA - A PILOT-STUDY, Addictive behaviors, 23(2), 1998, pp. 263-266
Authors:
SALOKANGAS RKR
SAARIJARVI S
TAIMINEN T
LEHTO H
NIEMI H
AHOLA V
SYVALAHTI E
Citation: Rkr. Salokangas et al., EFFECT OF SMOKING ON NEUROLEPTICS IN SCHIZOPHRENIA, Schizophrenia research, 23(1), 1997, pp. 55-60
Authors:
SYVALAHTI EKG
TAIMINEN T
SAARIJARVI S
LEHTO H
NIEMI H
AHOLA V
DAHL ML
SALOKANGAS RKR
Citation: Ekg. Syvalahti et al., CITALOPRAM CAUSES NO SIGNIFICANT ALTERATIONS IN PLASMA NEUROLEPTIC LEVELS IN SCHIZOPHRENIC-PATIENTS, Journal of international medical research, 25(1), 1997, pp. 24-32
Authors:
TAIMINEN TJ
SYVALAHTI E
SAARIJARVI S
NIEMI H
LEHTO H
AHOLA V
SALOKANGAS RKR
Citation: Tj. Taiminen et al., CITALOPRAM AS AN ADJUVANT IN SCHIZOPHRENIA - FURTHER EVIDENCE FOR A SEROTONERGIC DIMENSION IN SCHIZOPHRENIA, International clinical psychopharmacology, 12(1), 1997, pp. 31-35
Authors:
TAIMINEN T
SYVALAHTI E
SAARIJARVI S
NIEMI H
LEHTO H
AHOLA V
SALOKANGAS RKR
Citation: T. Taiminen et al., IS POSITIVE PLACEBO-RESPONSE IN CHRONIC-SCHIZOPHRENIA INVESTIGATOR-DEPENDENT, The Journal of nervous and mental disease, 185(10), 1997, pp. 644-645
Authors:
TAIMINEN T
SYVALAHTI E
SAARIJARVI S
NIEMI H
LEHTO H
AHOLA V
SALOKANGAS RKR
Citation: T. Taiminen et al., PREDICTION OF POSITIVE PLACEBO-RESPONSE AMONG CHRONIC-SCHIZOPHRENIC OUTPATIENTS, The Journal of nervous and mental disease, 184(2), 1996, pp. 109-113
Authors:
SALOKANGAS RKR
SAARIJARVI S
TAIMINEN T
KALLIONIEMI H
LEHTO H
NIEMI H
TUOMINEN J
AHOLA V
SYVALAHTI E
Citation: Rkr. Salokangas et al., CITALOPRAM AS AN ADJUVANT IN CHRONIC-SCHIZOPHRENIA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Acta psychiatrica Scandinavica, 94(3), 1996, pp. 175-180
Risultati:
1-7
|